Join all stakeholders—patients, researchers, companies, investors, thought leaders and government—for a unique opportunity for all who are focused on rare diseases to gain a common understanding of the previous and emerging challenges and opportunities and strategies for the future.
Take advantage of separate tracks for patients, researchers, companies, and investors, in addition to high-level plenary sessions where leading researchers, company officials, patient organizations and government leaders will discuss how the various interests can collaborate more productively.
Register and view the program at: US Conference on Rare Diseases and Orphan Products ►
DIA About the Conference - Drug Information Association: "- Enviado mediante la barra Google"
No hay comentarios:
Publicar un comentario